There are 2867 resources available
903O - A prospective study of a multi-cancer early detection blood test
Presenter: Deborah Schrag
Session: Proffered Paper session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
LBA4 - Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial
Presenter: Robert Motzer
Session: Presidential Symposium II
Resources:
Abstract
Slides
Webcast
MCBS: The future of cost-effective care
Presenter: Felipe Roitberg
Session: The enigma of public policy in oncology: ESMO at the forefront
Resources:
Slides
Webcast
1696O - Genomic profiling and molecular targeting of lung cancer brain metastases
Presenter: Haiying Cheng
Session: Proffered Paper session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
526MO - Pathological assessment of sentinel lymph node in early-stage cervical cancer: Results from the prospective SENTIX trial (CEEGOG-CX01; ENGOT-CX2)
Presenter: David Cibula
Session: Mini Oral session 2: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
LBA5 - Primary results of the phase III KEYNOTE-412 study: Pembrolizumab (pembro) with chemoradiation therapy (CRT) vs placebo plus CRT for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC)
Presenter: Jean-Pascal Machiels
Session: Presidential Symposium II
Resources:
Abstract
Slides
Webcast
GDPR in oncology: The EU experience
Presenter: Paolo G. Casali
Session: The enigma of public policy in oncology: ESMO at the forefront
Resources:
Slides
Webcast
Cachexia
Presenter: Jann Arends
Session: Minimizing some of the most distressing cancer and cancer treatment related symptoms
Resources:
Slides
Webcast
Invited Discussant 525MO and 526MO
Presenter: Philipp Harter
Session: Mini Oral session 2: Gynaecological cancers
Resources:
Slides
Webcast
66O - MyPathway: A multiple target, multiple basket study of targeted treatments in tissue-agnostic cohorts of patients (pts) with advanced solid tumors
Presenter: Claire Friedman
Session: Proffered Paper session: Basic science & translational research
Resources:
Abstract
Slides
Webcast